Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

NSE:MADHAVBAUG Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	4.37	23.6	23.73	17.64	25.61
Short-Term Investments	226.28	133.41	159.87	137.95	166.07
Cash & Short-Term Investments	230.65	157.02	183.59	155.59	191.68
Cash Growth	46.89%	-14.48%	18.00%	-18.83%	2018.51%
Accounts Receivable	102.29	74.68	60.5	59.9	35.59
Other Receivables	-	0.17	5.18	-	-
Receivables	102.64	75.54	69.26	62.22	37.49
Inventory	36.48	37.56	41.14	34.14	15.01
Prepaid Expenses	2.58	3.16	13.63	7.69	0.79
Other Current Assets	70.75	33.14	5.89	18.21	27.3
Total Current Assets	443.1	306.41	313.52	277.84	272.27
Property, Plant & Equipment	240.85	227.08	230.25	201.06	171.95
Long-Term Investments	172.56	79.67	20.03	15.35	48.81
Goodwill	46.52	46.52	46.52	-	-
Other Intangible Assets	79.41	75.6	29.52	25.13	10.44
Long-Term Deferred Tax Assets	1.47	-	0.73	0.75	-0.48
Other Long-Term Assets	61.18	54.31	56.58	27.92	14.08
Total Assets	1,045	789.59	697.14	548.84	517.07

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	65.68	65.24	71	89.65	73.79
Accrued Expenses	16.12	18.09	22.89	24.83	31.83
Short-Term Debt	-	-	16.78	1.34	10.63
Current Income Taxes Payable	21.5	30.98	-	-	12.18
Other Current Liabilities	7.81	5.51	5.52	12.94	14.16
Total Current Liabilities	111.11	119.82	116.19	128.76	142.59
Long-Term Debt	25.85	14.77	-	-	-
Pension & Post-Retirement Benefits	15.67	13.87	10.63	12.61	11.63
Long-Term Deferred Tax Liabilities	-	0.49	-	-	-
Other Long-Term Liabilities	18.07	15.11	14.28	2.92	4.02
Total Liabilities	170.7	164.05	141.1	144.3	158.24

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	105.16	105.21	105.16	105.14	105.14
Additional Paid-In Capital	191.08	191.08	191.08	191.08	191.08
Retained Earnings	288.4	197.12	125.48	108.31	62.61
Comprehensive Income & Other	289.73	132.12	134.31	-	-
Total Common Equity	874.36	625.53	556.03	404.53	358.83
Minority Interest	0.01	0.01	0.01	0.02	-
Shareholders' Equity	874.37	625.54	556.04	404.54	358.83
Total Liabilities & Equity	1,045	789.59	697.14	548.84	517.07

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	25.85	14.77	16.78	1.34	10.63
Net Cash (Debt)	204.79	142.24	166.81	154.25	181.05
Net Cash Growth	43.98%	-14.73%	8.14%	-14.80%	-
Net Cash Per Share	18.31	11.53	13.52	14.67	17.22
Filing Date Shares Outstanding	10.52	10.52	10.51	10.51	10.51
Total Common Shares Outstanding	10.52	10.52	10.51	10.51	10.51
Working Capital	331.99	186.59	197.33	149.08	129.68
Book Value Per Share	83.11	59.46	52.89	38.48	34.13
Tangible Book Value	748.44	503.41	479.99	379.39	348.39
Tangible Book Value Per Share	71.14	47.85	45.65	36.09	33.14
Land	3.42	3.42	3.42	3.24	3.24
Buildings	116.6	115.54	108.67	97.27	93
Machinery	292.09	258.72	237.64	189.06	150.89
Construction In Progress	21.44	12.62	17.6	16.72	12.31

Data Source: S&P Global Market Intelligence Last updated: Sep 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 30, 2026

Data Sources Report a data error